Delivery to
Bangladesh
All
Search for "medicine products"
Search for "healthcare products"
Search for "beauty products"
Search for "medicine products"
Search for "healthcare products"
Search for "beauty products"
Search for "medicine products"
Search for "healthcare products"
Search for "beauty products"
Search for "healthcare products"
Hello, User
Account & Orders
0
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register
0 People recently viewed this

Emfogen M 12.5/1000

tablet - (12.5mg+1000mg)

0.0/5

(0) Ratings

arogga-brand
General Pharmaceuticals Ltd.
Generic: Empagliflozin + Metformin Hydrochloride
151.20
৳ 168
10% OFF
Safety Advices
বাংলা
English
UNSAFE
It is unsafe to consume Emfogen M 12.5/1000 with alcohol.
UNSAFE
Emfogen M 12.5/1000 should not be used during pregnancy.
UNSAFE
Emfogen M 12.5/1000 should not be used during breastfeeding.
CAUTION
Emfogen M 12.5/1000 may cause dizziness or orthostatic hypotension (low blood pressure when standing up), which can impair ability to drive.
CONSULT YOUR DOCTOR
It is important to talk to your doctor about the risks and benefits of taking Emfogen M 12.5/1000 before starting treatment. Emfogen M 12.5/1000 should not be given to patients with serious kidney disease.
CAUTION
Emfogen M 12.5/1000 may not be suitable for patients with severe liver impairment.

Medicine Overview of Emfogen M 12.5/1000 12.5mg+1000mg tablet

Introduction
Emfogen M 12.5/1000 is a combination of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor and metformin hydrochloride, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin hydrochloride is appropriate.Emfogen M 12.5/1000 is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease. However, the effectiveness of Emfogen M 12.5/1000 on reducing the risk of cardiovascular death in adults with type 2 diabetes mellitus and cardiovascular disease has not been established.
Uses of Emfogen M 12.5/1000
Emfogen M 12.5/1000 use as a treatment of adults with type 2 diabetes mellitus.
Side effects of Emfogen M 12.5/1000
  • Nausea
  • Vomiting
  • Diarrhea
  • Headaches
  • Dizziness
  • Fatigue
  • Abdominal pain
  • Increased urination
  • Weight loss
How to use Emfogen M 12.5/1000
Take Emfogen M 12.5/1000 in the dose and duration prescribed by your doctor. Swallow it whole. Don't chew, crush, or break it. Emfogen M 12.5/1000 should be taken with food.
How Emfogen M 12.5/1000 works
By blocking SGLT2,Emfogen M 12.5/1000 prevents glucose from being reabsorbed and allows it to be excreted in the urine.Also work by decreasing the production of glucose in the liver and increasing the sensitivity of cells to insulin and lowers blood sugar levels.
What if you forget to take Emfogen M 12.5/1000 ?
If you forget to take yourEmfogen M 12.5/1000 , take them as soon as you remember. If it is almost time for your next dose, skip the missed dose and take it at the usual time. Avoid taking two doses at the same time.
Brief Description
Indication
Indicated for the treatment of adults with Type 2 Dabetes Mellitus as an adjunct to diet and exercise.
Administration
The dosage should be adjusted according to effectiveness and tolerability. Take this combination twice a day, with meals. To reduce the gastrointestinal side effects associated with Metformin Hydrochloride, dose escalation should be gradual. The maximum recommended daily dose of Metformin Hydrochloride is 2000 mg, while Empagliflozin is 25 mg.
Adult Dose
The standard starting dose for empagliflozin + metformin hydrochloride is 5 mg of empagliflozin and 500 mg of metformin hydrochloride once daily. The dose can be gradually increased to a maximum of 25 mg of empagliflozin and 2,000 mg of metformin hydrochloride per day.
Child Dose
The safety and efficacy of this medication in children under the age of 18 has not been established.
Renal Dose
Before starting this combination with a renally impaired patient, assess their renal function.In patients with an eGFR below 45 mL/min/1.73 m2 is contraindicated.
Contraindication
•Type 1 diabetes •Diabetic ketoacidosis (DKA) •Severe kidney disease (eGFR < 30 mL/min/1.73 m2) •Severe liver disease •Heart failure •Active bladder infection •Recent surgery or major trauma •Hypersensitivity to empagliflozin or metformin hydrochloride History of lactic acidosis. • History of urinary tract infections or genital yeast infections •Risk of dehydration •Elderly patients
... Show more
Mode of Action
By blocking SGLT2, empagliflozin prevents glucose from being reabsorbed and allows it to be excreted in the urine and decreasing the production of glucose in the liver and increasing the sensitivity of cells to insulin .It work synergistically to lower blood sugar levels more effectively.
Precautions
Empagliflozin + metformin hydrochloride should not be used by individuals with - • Type 1 diabetes. • Diabetic ketoacidosis • Severe kidney disease • Severe liver diseases • Heart failure. • Active bladder infection. • Recent surgery or significant trauma
Side Effect
Serious side effects: • Diabetic ketoacidosis (DKA) • Lactic acidosis • Hypoglycemia (low blood sugar) • Dehydration • Urinary tract infections • Female genital mycotic infections • urticaria, dysuria • Vaginal moniliasisia Common side effects : • Increased urination • Thirst • Dry mouth • Nausea • Vomiting • Diarrhea • Abdominal pain • Headache • Dizziness • Fatigue • Weight loss
Pregnancy & Lactation Category Note
Pregnancy: It is s not recommended for use during pregnancy due to potential risk to a fetus especially during the second and third trimesters. Lactation: Empagliflozin is excreted in breast milk and may be harmful to the nursing infant. Metformin hydrochloride is also excreted in breast milk, but it is unclear whether it can harm a nursing infant.
Interaction
It may interact with other medications, including: •Insulin: Empagliflozin + metformin hydrochloride can increase the risk of hypoglycemia (low blood sugar) when used with insulin. •Sulfonylureas: Empagliflozin + metformin hydrochloride can also increase the risk of hypoglycemia when used with sulfonylureas, another type of medication used to treat type 2 diabetes. •Meglitinides: Empagliflozin + metformin hydrochloride can also increase the risk of hypoglycemia when used with meglitinides, another type of medication used to treat type 2 diabetes. •Thiazolidinediones: Empagliflozin + metformin hydrochloride may increase the risk of heart failure when used with thiazolidinediones, another type of medication used to treat...
... Show more
Storage Conditions
Store below 30°C temperature, protected from light & moisture. Keep out of the reach of children.
... Show more
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register
0 People recently viewed this

Emfogen M 12.5/1000

tablet - (12.5mg+1000mg)

0.0/5

(0) Ratings

arogga-brand
General Pharmaceuticals Ltd.
Generic: Empagliflozin + Metformin Hydrochloride
151.20
৳ 168
10% OFF

Alternative Brands For Emfogen M 12.5/1000

Sort by:
Relevance
Disclaimer
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not be treated as a replacement for physical medical consultation or advice. We do not guarantee the accuracy and the completeness of the information so provided. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company. We do not take any responsibility for the consequences arising out of the aforementioned information and strongly recommend you for a physical consultation in case of any queries or doubts.